Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1995;25:154

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Frohlich, E. D.
Right arrow Articles by Ré, R. N.

(Hypertension. 1995;25:154.)
© 1995 American Heart Association, Inc.


Articles

Theodore Cooper Memorial Lectureship

Edward D. Frohlich, Editor-in-Chief; L. Gabriel Navar, Associate Editor; Richard N. Ré, Associate Editor

*    Introduction
 
With this issue of the journal, we initiate a new periodic series of articles honoring a major leader in cardiovascular biomedical sciences and a strong supporter of research and education in hypertension. Through an educational grant-in-aid from the Upjohn Company, innovative investigators in the field of hypertension and related areas will honor the memory of Theodore Cooper, MD, PhD (Fig 1), who was an outstanding fundamental and clinical investigator, a superb leader in medical education and in industry, and a visionary in biomedical and health administration.



View larger version (152K):
[in this window]
[in a new window]
 
Figure 1. Theodore Cooper, MD, PhD.

After his graduation and training as a cardiovascular surgeon at St Louis University, Ted worked at the National Institutes of Health (NIH) where he had a productive investigative career. He worked on problems dealing with cardiac transplantation, ventricular innervation and function, artificial hearts, and myocardial infarction. After a brief period as Chairman of the Department of Pharmacology at the University of New Mexico School of Medicine, he returned to the National Heart Institute to participate in a new program in research administration under the directorship of Robert P. Grant, MD. This led to many research innovations, including the initiation of myocardial infarction units and new designs in mechanisms for research grants that included Specialized Centers of Research, which were designed to bring fundamental research to the clinical setting. After the sudden death of Dr Grant, Ted assumed the directorship, providing guidance during some very exciting days at "the Institute."

During the administration of President Richard Nixon, Dr . . . [Full Text of this Article]